These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 32923163)

  • 1. Recombinant viruses delivering the necroptosis mediator MLKL induce a potent antitumor immunity in mice.
    Van Hoecke L; Riederer S; Saelens X; Sutter G; Rojas JJ
    Oncoimmunology; 2020 Aug; 9(1):1802968. PubMed ID: 32923163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new MVA ancestor-derived oncolytic vaccinia virus induces immunogenic tumor cell death and robust antitumor immune responses.
    Rojas JJ; Van Hoecke L; Conesa M; Bueno-Merino C; Del Canizo A; Riederer S; Barcia M; Brosinski K; Lehmann MH; Volz A; Saelens X; Sutter G
    Mol Ther; 2024 Jul; 32(7):2406-2422. PubMed ID: 38734899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment with mRNA coding for the necroptosis mediator MLKL induces antitumor immunity directed against neo-epitopes.
    Van Hoecke L; Van Lint S; Roose K; Van Parys A; Vandenabeele P; Grooten J; Tavernier J; De Koker S; Saelens X
    Nat Commun; 2018 Aug; 9(1):3417. PubMed ID: 30143632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of virus-mediated immunogenic cancer cell death and the consequences for oncolytic virus-based immunotherapy of cancer.
    Ma J; Ramachandran M; Jin C; Quijano-Rubio C; Martikainen M; Yu D; Essand M
    Cell Death Dis; 2020 Jan; 11(1):48. PubMed ID: 31969562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Replication efficiency of oncolytic vaccinia virus in cell cultures prognosticates the virulence and antitumor efficacy in mice.
    Chen NG; Yu YA; Zhang Q; Szalay AA
    J Transl Med; 2011 Sep; 9():164. PubMed ID: 21951588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intratumoral expression of interleukin 23 variants using oncolytic vaccinia virus elicit potent antitumor effects on multiple tumor models via tumor microenvironment modulation.
    Chen L; Chen H; Ye J; Ge Y; Wang H; Dai E; Ren J; Liu W; Ma C; Ju S; Guo ZS; Liu Z; Bartlett DL
    Theranostics; 2021; 11(14):6668-6681. PubMed ID: 34093846
    [No Abstract]   [Full Text] [Related]  

  • 7. Improving poxvirus-mediated antitumor immune responses by deleting viral cGAMP-specific nuclease.
    Riederer S; Del Canizo A; Navas J; Peter MG; Link EK; Sutter G; Rojas JJ
    Cancer Gene Ther; 2023 Jul; 30(7):1029-1039. PubMed ID: 37016144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor necroptosis-mediated shedding of cell surface proteins promotes metastasis of breast cancer by suppressing anti-tumor immunity.
    Liu Z; Choksi S; Kwon HJ; Jiao D; Liu C; Liu ZG
    Breast Cancer Res; 2023 Jan; 25(1):10. PubMed ID: 36703228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of DAI-dependent necroptosis by the Z-DNA binding domain of the vaccinia virus innate immune evasion protein, E3.
    Koehler H; Cotsmire S; Langland J; Kibler KV; Kalman D; Upton JW; Mocarski ES; Jacobs BL
    Proc Natl Acad Sci U S A; 2017 Oct; 114(43):11506-11511. PubMed ID: 29073079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccinia virus E3 prevents sensing of Z-RNA to block ZBP1-dependent necroptosis.
    Koehler H; Cotsmire S; Zhang T; Balachandran S; Upton JW; Langland J; Kalman D; Jacobs BL; Mocarski ES
    Cell Host Microbe; 2021 Aug; 29(8):1266-1276.e5. PubMed ID: 34192517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sulfate Radical Based In Situ Vaccine Boosts Systemic Antitumor Immunity via Concurrent Activation of Necroptosis and STING Pathway.
    Huang Y; Zou J; Huo J; Zhang M; Yang Y
    Adv Mater; 2024 Oct; 36(41):e2407914. PubMed ID: 39148154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opposite Effects of Apoptotic and Necroptotic Cellular Pathways on Rotavirus Replication.
    Soliman M; Seo JY; Baek YB; Park JG; Kang MI; Cho KO; Park SI
    J Virol; 2022 Jan; 96(1):e0122221. PubMed ID: 34668777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viral MLKL Homologs Subvert Necroptotic Cell Death by Sequestering Cellular RIPK3.
    Petrie EJ; Sandow JJ; Lehmann WIL; Liang LY; Coursier D; Young SN; Kersten WJA; Fitzgibbon C; Samson AL; Jacobsen AV; Lowes KN; Au AE; Jousset Sabroux H; Lalaoui N; Webb AI; Lessene G; Manning G; Lucet IS; Murphy JM
    Cell Rep; 2019 Sep; 28(13):3309-3319.e5. PubMed ID: 31553902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The NS1 Protein of Influenza A Virus Participates in Necroptosis by Interacting with MLKL and Increasing Its Oligomerization and Membrane Translocation.
    Gaba A; Xu F; Lu Y; Park HS; Liu G; Zhou Y
    J Virol; 2019 Jan; 93(2):. PubMed ID: 30355688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccinia virus evasion of regulated cell death.
    Veyer DL; Carrara G; Maluquer de Motes C; Smith GL
    Immunol Lett; 2017 Jun; 186():68-80. PubMed ID: 28366525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thioredoxin-1 actively maintains the pseudokinase MLKL in a reduced state to suppress disulfide bond-dependent MLKL polymer formation and necroptosis.
    Reynoso E; Liu H; Li L; Yuan AL; Chen S; Wang Z
    J Biol Chem; 2017 Oct; 292(42):17514-17524. PubMed ID: 28878015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smac mimetics and TRAIL cooperate to induce MLKL-dependent necroptosis in Burkitt's lymphoma cell lines.
    Koch A; Jeiler B; Roedig J; van Wijk SJL; Dolgikh N; Fulda S
    Neoplasia; 2021 May; 23(5):539-550. PubMed ID: 33971465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A class of viral inducer of degradation of the necroptosis adaptor RIPK3 regulates virus-induced inflammation.
    Liu Z; Nailwal H; Rector J; Rahman MM; Sam R; McFadden G; Chan FK
    Immunity; 2021 Feb; 54(2):247-258.e7. PubMed ID: 33444549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereotactic body radiation combined with oncolytic vaccinia virus induces potent anti-tumor effect by triggering tumor cell necroptosis and DAMPs.
    Chen WY; Chen YL; Lin HW; Chang CF; Huang BS; Sun WZ; Cheng WF
    Cancer Lett; 2021 Dec; 523():149-161. PubMed ID: 34606928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colonization of xenograft tumors by oncolytic vaccinia virus (VACV) results in enhanced tumor killing due to the involvement of myeloid cells.
    Kilinc MO; Ehrig K; Pessian M; Minev BR; Szalay AA
    J Transl Med; 2016 Dec; 14(1):340. PubMed ID: 27993141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.